Key Opinion Leaders and Pediatric Antidepressant Overprescribing
Abstract
The lingering controversy concerning the usefulness and safety of antidepressants for children and adolescents is likely to confuse clinicians. Recent papers perpetuate the claim that antidepressants are shown to be safe and effective in randomised controlled trials. Others claim that antidepressants have been shown to prevent suicides. In this editorial we address the manipulation of outcomes that result from academics’ alliance with industry. We explain how industry and key opinion leaders have distorted the clinician’s perception of the safety and usefulness of antidepressants for the treatment of depression in children and adolescents through publication bias, poor methodology, and selective reporting.